Individual Case Safety Reports (ICSRs) - from Narrative Writing to Causality Assessment

Learn to structure a narrative that supports the reported adverse event and the causality assessment
27 Sep 2022

1 day course

English

6,150 DKK ex VAT
(app. 827 EUR ex VAT)
50% DISCOUNT FOR PUBLIC INSTITUTIONS

Summary

In a continuously growing pharmacovigilance environment, there is an increasing demand for a high-quality level of data entry and medical evaluation leading to ICSRs of high quality.

In this interactive course, you learn how to structure a narrative that captures all relevant clinical and other information to support the reported adverse event and the causality assessment. We discuss a number of ICSRs from various sources (from spontaneous to clinical trials) and assess the causality.

Key words

  • Individual Case Safety Reports (ICSRs)
  • Narrative writing
  • Causality assessment
  • Regulatory requirements
  • Company Comments

    ANNIVERSARY OFFER:

    Book any course* scheduled for a date in 2022 and bring a colleague along: 2 for the price of 1. Only valid for bookings made 2 May until 16 May.

    Sign up yourself and a colleague in the same order form – then we make sure only one course fee is charged.

    (*Networks and courses offered together with University of Copenhagen and CBS are not included.)

Read more

Course leader(s) & Lecturer(s)

  • Claudia Pierleoni-Nielsen
    Course leader
    Senior Director, Head of Medical Safety
    Lundbeck A/S
  • Terrie Ramirez-Andersen
    Course leader
    Director, Clinical Research Scientist
    Genmab A/S
See all

IS THIS COURSE FOR YOU?

You work as a professional within pharmacovigilance, and already understand the basic principles of causality assessment.

What you will learn

  1. You will learn how to critically analyse and assess ICSRs and how to write company comments in the regulatory framework
  2. You will assess and discuss a number of ICSRs from various sources (from spontaneous to clinical trials) and a variety of medical event types

What your company will get

  1. An employee who understands the ICSRs’ value and who can critically analyse and assess ICSRs
  2. A pharmacovigilance professional who knows when and how to write comments to ICSRs
  3. A pharmacovigilance professional who can provide valuable input to all other team members working with ICSRs

Course calendar

27 Sep 2022 8:30-16:00
  • Principles of Causality Assessment
  • Narrative writing
  • Company’s Comments & Regulatory Perspective
  • Workshops
  • Rounding up

Practical information

Registration

Registration deadline
13 Sep 2022
Atrium
Lersø Parkallé 101
2100 København Ø
Register
27 Sep
Sometimes things change. This is the expected programme.

Course information

Literature

Prior to the course you will get access to mandatory and optional readings via your personal Atrium log-in.

Please familiarise yourself with the mandatory readings before starting the course.

Course leader(s)

Claudia Pierleoni-Nielsen
Senior Director, Head of Medical Safety
Lundbeck A/S
Terrie Ramirez-Andersen
Director, Clinical Research Scientist
Genmab A/S

Lecturer(s)

Claudia Pierleoni-Nielsen
Senior Director, Head of Medical Safety
Lundbeck A/S
Terrie Ramirez-Andersen
Director, Clinical Research Scientist
Genmab A/S

You may also be interested in these courses

WANT TO KNOW MORE or need help?

Contact Educational Programme Leader Lone Rex at +45 20 62 11 46

Send me a message